Tallarico, M.; Palleria, C.; Ruffolo, L.; Spagnuolo, R.; Naturale, M.D.; De Francesco, A.E.; De Sarro, C.; Romeo, R.; Citraro, R.; Doldo, P.;
et al. Biologics for Inflammatory Bowel Disease in Clinical Practice: A Calabria (Southern Italy) Prospective Pharmacovigilance Study. Pharmaceutics 2022, 14, 2449.
https://doi.org/10.3390/pharmaceutics14112449
AMA Style
Tallarico M, Palleria C, Ruffolo L, Spagnuolo R, Naturale MD, De Francesco AE, De Sarro C, Romeo R, Citraro R, Doldo P,
et al. Biologics for Inflammatory Bowel Disease in Clinical Practice: A Calabria (Southern Italy) Prospective Pharmacovigilance Study. Pharmaceutics. 2022; 14(11):2449.
https://doi.org/10.3390/pharmaceutics14112449
Chicago/Turabian Style
Tallarico, Martina, Caterina Palleria, Livia Ruffolo, Rocco Spagnuolo, Maria Diana Naturale, Adele Emanuela De Francesco, Caterina De Sarro, Rossella Romeo, Rita Citraro, Patrizia Doldo,
and et al. 2022. "Biologics for Inflammatory Bowel Disease in Clinical Practice: A Calabria (Southern Italy) Prospective Pharmacovigilance Study" Pharmaceutics 14, no. 11: 2449.
https://doi.org/10.3390/pharmaceutics14112449
APA Style
Tallarico, M., Palleria, C., Ruffolo, L., Spagnuolo, R., Naturale, M. D., De Francesco, A. E., De Sarro, C., Romeo, R., Citraro, R., Doldo, P., Abenavoli, L., Gallelli, L., Luzza, F., Leo, A., & De Sarro, G.
(2022). Biologics for Inflammatory Bowel Disease in Clinical Practice: A Calabria (Southern Italy) Prospective Pharmacovigilance Study. Pharmaceutics, 14(11), 2449.
https://doi.org/10.3390/pharmaceutics14112449
